Core Viewpoint - The article highlights the active role of Taikang Life as a cornerstone investor in the Hong Kong IPO market, particularly in sectors like AI, hard technology, biomedicine, and new consumption, indicating a strategic approach to long-term investment rather than opportunistic trading [2][10][12]. Investment Strategy - Taikang Life has participated in seven Hong Kong IPO projects since the beginning of 2026, securing nearly 1 billion HKD in allocations, showcasing its status as the most active insurer in the current market [2][10]. - The company employs a systematic investment strategy that includes cornerstone investments, strategic placements, and secondary market acquisitions, focusing on companies with established industry positions and clear growth paths [3][11][12]. Market Context - The overall insurance sector has shown a marginal shift towards IPOs and equity assets since 2025, driven by a low-interest-rate environment that compresses fixed-income returns, prompting insurers to seek new yield sources [13][14]. - Despite increased participation in IPOs, many insurers remain cautious, with Taikang Life distinguishing itself through a more consistent and strategic approach to investment [13][15]. Leadership Influence - The investment philosophy of Taikang Life is heavily influenced by its founder, Chen Dongsheng, who emphasizes long-term commitment and strategic foresight, having built the company in sectors that promise sustained growth [5][8][9]. Long-term Focus - Taikang Life's investments are not merely opportunistic but are aligned with its long-term liabilities, focusing on sectors that can provide stable returns over extended periods, such as hard technology and healthcare [12][15]. - The company has developed a comprehensive ecosystem around its insurance business, integrating healthcare and wellness services, which enhances its investment strategy and aligns with its long-term goals [9][12]. Conclusion - Taikang Life's proactive stance in the IPO market reflects a well-thought-out strategy that balances risk and return, positioning it as a model for other insurers navigating similar market conditions [16][17].

Core Viewpoint - The domestic AI chip unicorn, Hanbo Semiconductor, has completed its guidance for the Sci-Tech Innovation Board IPO, alongside Suiyuan Technology, marking a significant moment for the AI chip sector in China as it gathers six notable companies in the capital market, showcasing the rapid development of artificial intelligence [1] Group 1: Company Developments - Hanbo Semiconductor is advancing its IPO process and is recognized for its commercial success in both general AI and rendering applications, leading in the domestic data center AI and edge computing sectors [3][5] - Suiyuan Technology has developed four generations of cloud AI chips and aims to raise 6 billion yuan for the R&D and industrialization of its fifth and sixth-generation products [5] - The "Six Little Dragons" of AI chips, including companies like Moer Thread and Muxi, are focusing on technological advancements and product updates, with Muxi launching a new GPU product line [2][3][4] Group 2: Market Trends - The domestic general GPU market share is expected to rise from 8.3% in 2022 to 17.4% in 2024, with projections indicating it could exceed 50% by 2029 [13] - The AI chip market is experiencing structural changes, with companies transitioning from relying on external support to achieving self-sustained growth [13] - The upcoming IPOs of these companies are anticipated to strengthen the trend of domestic AI chip localization, providing a stable financial foundation and increasing market recognition [12] Group 3: Government Support and Investment - Shanghai has positioned itself as a leader in the integrated circuit industry, ranking first in China and fourth globally, and is actively supporting local AI chip companies through funding and policy initiatives [7][8][10] - Significant investments have been made by Shanghai's state-owned enterprises in companies like Wallen Technology and Suiyuan Technology, facilitating their growth and technological advancements [9][10]

Core Viewpoint - The domestic AI chip industry in Shanghai is rapidly advancing, with six notable companies, referred to as the "Six Little Dragons," preparing for IPOs, indicating a strong growth trajectory in the AI sector and a significant opportunity for investment [1][9]. Group 1: Company Developments - Hanbo Semiconductor has completed its guidance for the Sci-Tech Innovation Board IPO and is progressing towards its public offering [1]. - Suiruan Technology has been accepted for its IPO application on the Sci-Tech Innovation Board, indicating a competitive landscape among domestic AI chip manufacturers [1]. - The "Six Little Dragons" include companies like Moer Thread, Muxi Co., Tian Shu Zhi Xin, and Bi Ran Technology, all of which are focusing on developing next-generation AI chips [2][3]. Group 2: Technological Advancements - The "Six Little Dragons" are primarily cloud-based AI chip manufacturers, with Moer Thread and Muxi Co. focusing on GPGPU architectures, while Suiruan Technology is developing specialized AI acceleration chips [2]. - Tian Shu Zhi Xin has announced a roadmap for its fourth-generation architecture, aiming to surpass NVIDIA's technology by 2027 [3]. - Moer Thread plans to unveil its new GPU architecture "Hua Gang" by the end of 2025, which will significantly enhance computing power and efficiency [3]. Group 3: Financial Performance and Projections - Moer Thread expects its revenue for 2025 to be between 1.45 billion to 1.52 billion yuan, reflecting a growth of approximately 230.7% to 246.67% compared to 2024 [9]. - Muxi Co. anticipates a revenue increase to between 1.6 billion to 1.7 billion yuan in 2025, marking a growth of 115.32% to 128.78% year-on-year [10]. - Both companies are experiencing a reduction in net losses, indicating a positive trend in financial performance amidst a growing market for AI chips [10][11]. Group 4: Government and Investment Support - Shanghai has positioned itself as a leader in the integrated circuit industry, ranking first in China and fourth globally, which has facilitated the growth of local AI chip companies [5]. - The Shanghai government has actively supported the development of the "Six Little Dragons" through funding and policy initiatives, enhancing their growth potential [6][8]. - Significant investments have been made in companies like Muxi Co. and Suiruan Technology, with funding from state-owned enterprises and investment funds aimed at bolstering their market positions [7][8].

转自：智通财经 智通财经2月7日讯（记者高艳云）2026年伊始，港股IPO市场仍保持高速态势。 今年以来，港股IPO融资额高达675.5亿元，同比增1029.23%，尚处于聆讯处理中的企业高达376家。就 此，甚至由此引发市场对IPO"堰塞湖"现象的担忧，但令人欣喜的是，港交所明确表示已安排足够人手 及资源，并称有信心保持40个工作日内完成审核并提供两轮意见的服务承诺。 中资券商在IPO保荐、承销两业务中均保持领先地位，其中中金公司位居年内港股IPO上市保荐、承销 两业务的冠军地位，华泰金控(香港)与中金香港在承销业务中断层领先其他券商；中金香港与中信香港 分别在聆讯处理中的项目分别多大103个、102个，各自占据近三成市场份额，优势显著。 开年IPO融资激增逾10倍 Wind数据统计显示，截至2月6日，港股股权融资总额880.15亿元，同比增614.95%，数量为84起，同比 增71.43%。 其中IPO融资总额为675.50亿元，同比增1029.23%，上市家数达18家，同比增125%；配售总额为181.98 亿元，同比增239.24%，数量为49起，同比增58.06%；供股总额为10.63亿元，同比增2 ...

面对庞大的上市需求，港交所与香港证券及期货事务监察委员会(简称"香港证监会")联合推出的"40个工 作日速审承诺"，旨在为材料达标的企业提供可预期的审核周期。 观察排队企业名单可以发现，在目前处于有效期内的递表公司中，软件服务、医疗保健、工业制造三大 行业合计占比已超六成。 今年1月，壁仞科技、智谱等明星科技公司密集挂牌，反映出制造高端化、智能化趋势在资本市场的显 著聚集。 中新社香港2月6日电 (记者 戴小橦)踏入2026年，香港IPO市场呈现显著的扩容态势。截至2月5日，港 股今年已迎来15家新股上市，募资总额达513.07亿元(港元，下同)，同比增长逾7倍。其中，东鹏饮料以 101亿元的募资额，成为2026年港股首个"百亿IPO"。 2月3日，中国内地企业东鹏饮料(集团)股份有限公司在香港交易所主板挂牌上市，股票名称为"东鹏饮 料"，代码为9980。图为东鹏饮料集团董事长林木勤(右)和品牌代言人韩红共同敲锣上市。 中新社记 者 侯宇 摄 据香港交易及结算所有限公司(简称"港交所")最新披露的数据，今年1月已新增近百宗申请；截至1月 底，正在处理的上市申请数量已达414家。 瑞银证券全球投资银行部联席主管 ...

Core Insights - The Hong Kong IPO market is showing a vibrant start in 2026, achieving a record of zero IPO failures for the month and solidifying its position as a key financing platform for global new economy enterprises [2][4] Hong Kong IPO Market Overview - As of January 31, 2026, a total of 13 companies (including GEM) were listed on the Hong Kong Stock Exchange, an increase of 5 companies compared to the same period last year, marking a significant growth [4] - The total amount raised through IPOs reached HKD 39.255 billion, a staggering increase of 556.22% year-on-year, marking Hong Kong's return to the top of the global IPO fundraising rankings after six years [4] - The fundraising structure is becoming more balanced and healthy, with 11 companies raising over HKD 1 billion, 7 over HKD 3 billion, and 5 over HKD 4 billion [5][6] Sector and Company Highlights - Five hard technology companies, including Wallen Technology, were the main contributors to the fundraising, each raising over HKD 4 billion [6] - The consumer sector, exemplified by the leisure food chain "Mingming is Busy," also demonstrated strong capital attraction [6] - The hard technology sector continues to attract significant capital, reinforcing its dominant position in the market [7] Upcoming IPOs and Applications - In the period from January 26 to February 1, 2026, three companies from the hard technology sector passed the listing hearing, indicating ongoing interest in this field [8] - A total of 121 new IPO applications were received in January 2026, showcasing a robust pipeline of industry-leading companies across various sectors [10] US IPO Market Overview - In January 2026, three companies completed their listings in the US, with two using the SPAC method, indicating a rising trend in SPACs among Chinese companies [13][14] - SPACs accounted for two-thirds of the completed listings, highlighting their growing significance in the fundraising landscape [14][19] - The fundraising data shows that SPACs have become the dominant force, raising over USD 200 million, which constitutes more than 95% of the total fundraising for the month [19] Regulatory Environment - The recent policy upgrades in the US have significantly raised the listing thresholds, prompting Chinese companies to focus on enhancing their core competitiveness and compliance [22]

截至2026年2月4日，港股IPO排队企业总共390家，其中有13家企业已通过聆讯。另外，东鹏饮料、国恩科技等股票已于2月上市。 1月有13只新股上市 2026年1月，港交所共有13只新股上市，合计募资总额达392.55亿港元，较2025年12月上市募资规模增超四成。 1月上市新股中，壁仞科技募资总额达64.2亿港元，规模最大。MINIMAX-WP紧随其后，募集约55.4亿港元。此外，豪威集团、兆易创新、智谱募资超过40 亿港元。 新华财经北京2月6日电新华财经和面包财经研究员根据香港交易所披露信息，对港股IPO排队及新上市企业进行了梳理统计。其中，港股IPO排队企业选取 依据为审核状态为已刊登申请版本、已刊登聆讯后资料集。 1月，港交所共有13只新股上市，合计募资总额达392.55亿港元，规模环比增超四成。其中，壁仞科技、MINIMAX-WP首发募集总额居前，分别达64.2亿港 元、55.4亿港元。 根据公开信息，截至2026年2月4日（下同），港交所的IPO排队企业总共390家。其中，主板IPO排队企业数量达384家，创业板（GEM，下同）排队企业6 家。 按审核进度汇总，已刊登申请版本的企业有377家， ...

日前，东鹏饮料登陆港交所，基石投资者中再现保险机构泰康人寿，这是今年泰康保险第7次参与港 股IPO的战略配售。 开年短短1个多月时间，以泰康保险为代表的险资加大了港股IPO的申购参与力度，作为基石投资者已参与了 壁仞科技、智谱、瑞博生物、MINIMAX-WP（稀宇科技）、兆易创新、鸣鸣很忙、东鹏饮料等7家新股申购， 累计获配资金达9.49亿港元。 去年以来，从险资参与港股IPO的情况看，泰康保险获配的家数最多。此外，中国平安也参与了壁仞科技的战 略配售，获配金额1.17亿港元；新华资产（香港）、大家人寿等险资也参与了兆易创新、豪威集团等港股IPO 项目。 险资近1个月获配7家港股IPO 港股IPO火热的战略配售，不止吸引了国际投资者，还吸引了越来越多的保险资金参与。 今年短短1个月时间，泰康保险（泰康人寿合并计算）已累计参与了7家港股IPO项目的国际配售。 其中，壁仞科技于1月2日在港交所挂牌上市，成为港股"国产GPU第一股"，泰康人寿便认购基石投资份额1000 万美元。此后，泰康保险又先后参与了智谱、瑞博生物、MINIMAX、兆易创新等港股IPO。 从获配金额来看，7家港股IPO项目累计认购金额达到9.49 ...

Group 1 - The core mission of the investment group is to make state-owned capital and fiscal funds the strongest support for technological innovation, fostering an industrial ecosystem through long-term investment strategies [4] - The "4+N" industrial fund cluster has established 52 funds with a total scale exceeding 130 billion yuan, aligning with major platform construction in Nanjing [4][5] - The establishment of the Zijinshan International Sci-Tech Innovation Fund District aims to create an international platform integrating policy support, capital empowerment, and industry-finance collaboration [4][5] Group 2 - Nanjing's investment in companies like Moer Thread and Muxi Co. has led to significant market performance, with Moer Thread's first-day increase exceeding 400% and Muxi Co. reaching a first-day increase of 692.95% [5] - The investment group has supported over 2,300 companies, including nearly 800 in Nanjing, with more than 320 high-tech enterprises and over 160 specialized and innovative enterprises [7] - The group has successfully hosted nine project roadshow events, attracting 104 quality projects in cutting-edge fields such as integrated circuits and intelligent manufacturing [6] Group 3 - The investment group has innovated financing channels by issuing three phases of technology innovation corporate bonds totaling 2 billion yuan, achieving historically low interest rates for similar bonds [8] - A new "investment-insurance linkage" model has been implemented, providing comprehensive insurance for technology research and development, effectively reducing the risk of R&D failures [8] - Digital transformation initiatives have enhanced the management capabilities of the group, integrating various systems for improved operational efficiency [9]

Core Insights - The domestic startup market in China is experiencing a surge in financing, with multiple companies securing over 1 billion yuan in funding, including notable firms like Jieyue Xingchen and Geely's flying car company WoFei ChangKong [1][2] Group 1: New Unicorns - In January 2026, 11 new unicorns emerged in China, spanning sectors such as AI, humanoid robots, healthcare, eVTOL, and quantum computing [2] - Humans& became a new unicorn after raising $480 million in seed funding, achieving a post-money valuation of $4.48 billion, backed by investors like NVIDIA and Google Ventures [3][4] - WoFei ChangKong, a subsidiary of Geely, completed nearly 1 billion yuan in financing, reaching a valuation of 10 billion yuan, focusing on low-altitude travel and flying car development [6][7][8] - ZiBian Robot secured 1 billion yuan in A++ round financing, achieving a post-money valuation of over $1 billion, with plans to enhance its humanoid robots and expand into various application scenarios [9] - RayNeo announced a new round of financing exceeding 1 billion yuan, achieving a valuation of $1 billion, and launched the world's first eSIM independent communication AR glasses [10][11] Group 2: IPO Activities - Six unicorn companies went public in January, all listed on the Hong Kong Stock Exchange, marking a concentrated IPO wave at the beginning of the year [12] - Notable IPOs include Zhiyuan, which raised 4.348 billion HKD, and Minimax, which raised 4.189 billion HKD, both focusing on AI and large model technologies [13] - Other companies like Biran Technology and Jingfeng Medical also completed IPOs, with respective fundraising targets of 5.583 billion HKD and 1.2 billion HKD [15] Group 3: Major Financing Events - Jieyue Xingchen completed over 5 billion yuan in B+ round financing, setting a record for the largest single financing in China's large model sector over the past year [16][18] - ByteDance's "Doubao" AI glasses are set to enter the market, with plans for a no-screen version to be released in Q1 2026 and a display version by Q4 2026 [19][20] - Baidu's Kunlun Chip has submitted a confidential IPO application, with a valuation of 21 billion yuan following its latest funding round [22][23]